Relationship Between Hypertension And Diabetes Mellitus Type 2 With Benign Prostate Hyperplasia In Mgr. Gabriel Manek Hospital Atambua
-
Adrianus Gupta Wijaya(1*)
Universitas Nusa Cendana
-
Arley Sadra Telussa(2)
Universitas Nusa Cendana
(*) Corresponding Author
Abstract
Objectives: To evaluate the relationship between hypertension (HT) and diabetes mellitus type 2 (DM type 2) with benign prostate hyperplasia (BPH).Material & methods:This is a case control study with group A (case) consist of 78 BPH patient and group B (control) consist of 78 non BPH patient. DM and HT status from each group was collected. Correlation between each variables and odds ratio was analyzed.Results: Mean age was 66.09 ± 9.05 and 63.40 ± 9.83 years in group A and group B respectively. There is a statistical significant correlation between HT (0.001) and DM (0.021) with BPH (p<0.05). Patient with hypertension are 7.8 times more likely to suffer from BPH (OR 7.882) and patient with DM are 3 times more likely to suffer from BPH.Conclusion: HT and DM type 2 are significantly related to BPH incidence in Mgr. Gabriel Manek Hospital. Patient with HT and DM type 2 are more likely to suffer from BPH. Prevention and management of HT and DM type 2 may help to reduce the incidence of BPH.
Downloads
References
2. Abdollah, F., Briganti, A., Suardi, N., Castiglione, F., Gallina, A., Capitanio, U., &Montorsi, F. (2011). Metabolic syndrome and benign prostatic hyperplasia: Evidence of a potential relationship, hypothesized etiology, and prevention. Korean Journal of Urology, 52(8), 507–516.
3. Kocjancic, E., &Iacovelli, V. (2018). Benign prostatic hyperplasia (BPH). In Encyclopedia of Reproduction (pp. 467–473). Elsevier.
4. Rył, A., Rotter, I., Miazgowski, T., Słojewski, M., Dołęgowska, B., Lubkowska, A., &Laszczyńska, M. (2015). Metabolic syndrome and benign prostatic hyperplasia: Association or coincidence? Diabetology and Metabolic Syndrome, 7(1).
5. Zeng, X. T., Weng, H., Jin, Y. H., Liu, T. Z., Liu, M. Y., & Wang, X. H. (2018, May 1). Association between Diabetes Mellitus and Hypertension in Benign Prostatic Hyperplasia Patients. Chinese Medical Journal.
6. Kitt, J., Fox, R., Tucker, K. L., & McManus, R. J. (2019, June 1). New Approaches in Hypertension Management: a Review of Current and Developing Technologies and Their Potential Impact on Hypertension Care. Current Hypertension Reports.
7. Riset Kesehatan Dasar(Riskesdas) (2018). Badan Penelitian dan Pengembangan Kesehatan Kementerian RItahun 2018.http://www.depkes.go.id/resources/download/infoterkini/materi_rakorpop_2018/Hasil%20Riskesdas%202018.pdf
8. Ni, X., Meng, H., Zhou, F., Yu, H., Xiang, J., & Shen, S. (2016). Effect of hypertension on bacteria composition of prostate biopsy in patients with benign prostatic hyperplasia and prostate cancer in PSA grey-zone. Biomedical Reports, 4(6), 765–769.
9. Wang, Z., &Olumi, A. F. (2011). Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia. Differentiation.
10. Kopp, W. (2018). Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension.Nutrition and Metabolic Insights, 11, 117863881877307.
11. Ozden, C., Ozdal, O. L., Urgancioglu, G., Koyuncu, H., Gokkaya, S., &Memis, A. (2007). The Correlation between Metabolic Syndrome and Prostatic Growth in Patients with Benign Prostatic Hyperplasia. European Urology, 51(1), 199–206.
12. Michel, M. C., Heemann, U., Schumacher, H., Mehlburger, L., &Goepel, M. (2004). Association of hypertension with symptoms of benign prostatic hyperplasia. Journal of Urology, 172(4 I), 1390–1393.
13. Devi, K., Frasiska, A., Agung, A., & Oka, G. (2018). Usia dan obesitasberhubunganterhadapterjadinyapenyakit benign prostatic hyperplasia di RSUP Sanglah Bali periodejanuari 2014 sampaidesember 2014. E-JurnalMedika, 7(1), 2–4.
Copyright Notice
This work is licensed under a Creative Commons Attribution 4.0 International License.
